Safety and Efficacy of Ruxolitinib (rux) in an Open-Label, Multicenter, Expanded Treatment Protocol in Patients (Pts) with Polycythemia Vera (PV) Who Are Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatments Are Available
| Autor: | Devos, Timothy, Pica, Gian Matteo *, Zerazhi, Hacene *, Van Droogenbroeck, Jan *, Visanica, Sorin *, Báez de la Fuente, Enrique *, Leber, Brian, Almeida, Antonio Medina de *, Ranta, Dana *, Martinez, Tomasa *, Kiladjian, Jean-Jacques, Chrit, Linda *, Yin, Zhaoyu *, Perez Ronco, Julian *, Foltz, Lynda |
|---|---|
| Zdroj: | In Blood 8 December 2017 130 Supplement 1:2918-2918 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|